| Literature DB >> 27882817 |
Yan Li1, Lin Li1, Ou Zeng1, Jun Mao Liu1, Jun Yang1.
Abstract
Nephropathy develops in many patients with type 1 diabetes mellitus (T1DM). However, the specific mechanisms and therapies remain unclear. For this purpose we investigated the effects of hydrogen sulfide (H2S) on renal fibrosis in streptozotocin (STZ) induced diabetic rats and its underlying mechanisms. Experimental rats were randomly divided into four groups: Control group (normal rats), DM group (diabetes rats), DM + NaHS group [diabetes rats treated with sodium hydrosulfide (NaHS)], and NaHS group (normal rats treated with NaHS). The diabetic models were established by intraperitoneal injection of STZ. The NaHS-treated rats were injected with NaHS as an exogenous donor of H2S. At the same time, control group and DM group were administrated with equal doses of normal saline (NS). After eight weeks, the rats' urine samples were collected to measure the renal hydroxyproline content by basic hydrolysis method with a hydroxyproline detection kit. Collagen I and III content was detected by immunohistochemical method, and the pathology morphology of kidney was analyzed by Masson staining. Protein expressions of transforming growth factor beta 1 (TGF-β1), ERK1/2, TIMP1, TIMP2, MMP-2, MMP-7, MMP-8, MMP-11, and MMP-14 were assessed by western blotting. The results showed that significant fibrosis occurred in the kidney of diabetes rats. NaHS treatment downregulated TGF-β1, ERK1/2, TIMP1, TIMP2, MMP-2, MMP-7, MMP-8, MMP-11, and MMP-14 expressions in the kidney of these diabetes rats (p<.01). This result suggests that NaHS treatment could attenuate renal fibrosis by TGF-β1 signaling, and its mechanisms may be correlated with ERK1/2 expression and modulation of MMPs/TIMPs expression. Therefore, H2S may provide a promising option for defensing against diabetic renal fibrosis through TGF-β1 signaling, equilibrating the balance between profibrotic and antifibrotic mediators.Entities:
Keywords: Hydrogen sulfide; diabetic renal fibrosis; extracellular signal-regulated kinase-1/2; matrix metalloproteinases/tissue inhibitors of metalloproteinases; transforming growth factor beta 1
Mesh:
Substances:
Year: 2016 PMID: 27882817 PMCID: PMC6014487 DOI: 10.1080/0886022X.2016.1257433
Source DB: PubMed Journal: Ren Fail ISSN: 0886-022X Impact factor: 2.606
Figure 1.Masson staining of kidney tissues. (A) A rat in control group, (B) a rat in DM group, (C) a rat in DM + NaHS group, and (D) a rat in NaHS group.
Figure 2.Immunohistochemistry study of collagen I (up) and collagen III (down) expression in kidney. (A) A rat in control group, (B) a rat in DM group, (C) a rat in DM + NaHS group, and (D) a rat in NaHS group.
Effects of hydrogen sulfide on 24-h urinary protein and 24-h urinary microalbumin excretion (mean ± SD).
| Groups | 24-h urinaryprotein excretion | 24-h urinarymicroalbuminexcretion |
|---|---|---|
| Control group | 11.8 ± 3.3 | 0.5 ± 0.3 |
| DM group | 44.5 ± 6.4 | 13.0 ± 2.6 |
| DM + NaHS group | 26.6 ± 6.1 | 5.9 ± 2.4 |
| NaHS group | 12.6 ± 4.0 | 0.6 ± 0.3 |
p<.01 vs. control group.
p<.01 vs. DM group.
Figure 3.Hydroxyproline content in kidney of each group.
Figure 4.TGF-β1 (A) and ERK1/2 (B) expression in the renal tissues from each group (normalized by GAPDH).
Figure 5.TIMP1 and TIMP2 expressions in the renal tissues from each group [normalized by glyceraldehyde-3-phosphate dehydrogenase (GAPDH)].
Figure 6.Expression of MMP-2, MMP-7, MMP-8, MMP-11, MMP-14 in the renal tissues from each group (normalized by GAPDH).